CASP3 and neoplasm: Addition of Enza to Tras further increased Casp3 + cells compared with Enza alone (p < 0.05) (Fig. 6c and d).These data revealed that Enza inhibits HCC1954 tumor growth via reduced cell proliferation and increased cell death, similar to the effects of trastuzumab on HCC1954.